These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 9200685

  • 21. Assessment of mechanistic proposals for the binding of agonists to cardiac muscarinic receptors.
    Wong HM, Sole MJ, Wells JW.
    Biochemistry; 1986 Nov 04; 25(22):6995-7008. PubMed ID: 3801407
    [Abstract] [Full Text] [Related]

  • 22. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
    Rinner I, Porta S, Schauenstein K.
    Endocrinol Exp; 1990 Mar 04; 24(1-2):125-32. PubMed ID: 2361455
    [Abstract] [Full Text] [Related]

  • 23. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
    Lazareno S, Birdsall NJ.
    Mol Pharmacol; 1995 Aug 04; 48(2):362-78. PubMed ID: 7651370
    [Abstract] [Full Text] [Related]

  • 24. Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-[35S]thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry.
    Jakubík J, Haga T, Tucek S.
    Mol Pharmacol; 1998 Nov 04; 54(5):899-906. PubMed ID: 9804625
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M, Stenstrom S, Richelson E.
    Mol Pharmacol; 1984 Sep 04; 26(2):156-63. PubMed ID: 6148690
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.
    Liebmann C, Nawrath S, Schnittler M, Schubert H, Jakobs KH.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan 04; 345(1):7-15. PubMed ID: 1538792
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
    Poyner DR, Birdsall NJ, Curtis C, Eveleigh P, Hulme EC, Pedder EK, Wheatley M.
    Mol Pharmacol; 1989 Sep 04; 36(3):420-9. PubMed ID: 2506431
    [Abstract] [Full Text] [Related]

  • 32. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y, Toyoshima R.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):49-58. PubMed ID: 16182280
    [Abstract] [Full Text] [Related]

  • 33. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
    Muma NA, Mariyappa R, Williams K, Lee JM.
    Synapse; 2003 Jan 03; 47(1):58-65. PubMed ID: 12422374
    [Abstract] [Full Text] [Related]

  • 34. An unusual form of the association binding kinetics of N-[3H]methylscopolamine to the split muscarinic M2trunk/M2tail receptor.
    Novi F, Scarselli M, Corsini GU, Maggio R.
    J Pharmacol Exp Ther; 2003 May 03; 305(2):786-95. PubMed ID: 12606698
    [Abstract] [Full Text] [Related]

  • 35. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
    Wreggett KA, Wells JW.
    J Biol Chem; 1995 Sep 22; 270(38):22488-99. PubMed ID: 7673239
    [Abstract] [Full Text] [Related]

  • 36. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.
    Brown JH, Goldstein D.
    Mol Pharmacol; 1986 Dec 22; 30(6):566-70. PubMed ID: 3023810
    [Abstract] [Full Text] [Related]

  • 37. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
    Graeser D, Neubig RR.
    Mol Pharmacol; 1993 Mar 22; 43(3):434-43. PubMed ID: 8095695
    [Abstract] [Full Text] [Related]

  • 38. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
    Ehlert FJ, Delen FM.
    Mol Pharmacol; 1990 Jul 22; 38(1):143-7. PubMed ID: 2370852
    [Abstract] [Full Text] [Related]

  • 39. Relationship between muscarinic receptor occupancy and response in rat parotid acinar cells.
    Dai Y, Baum BJ.
    Am J Physiol; 1993 Dec 22; 265(6 Pt 1):G1122-7. PubMed ID: 8279563
    [Abstract] [Full Text] [Related]

  • 40. Fixation traps formyl peptide receptors in high and low affinity forms that can be regulated by GTP[S] in the absence of ligand.
    Domalewski MD, Guyer DA, Freer RJ, Muthukumaraswamy N, Sklar LA.
    J Recept Signal Transduct Res; 1996 Dec 22; 16(1-2):59-75. PubMed ID: 8771531
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.